Evidence map›Paper›PMID 37737609›Full record

ArticleMicrobiology spectrum2023

Mary C Moran, Matthew G Brewer, Patrick M Schlievert, Lisa A Beck

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mary C MoranDepartment of Dermatology, University of Rochester Medical Center , Rochester, New York, USA.ORCID 0000-0002-6456-082X
Matthew G BrewerDepartment of Dermatology, University of Rochester Medical Center , Rochester, New York, USA.ORCID 0000-0001-7631-5234
Patrick M SchlievertDepartment of Microbiology & Immunology, University of Iowa , Iowa City, Iowa, USA.ORCID 0000-0001-8314-9369
Lisa A BeckDepartment of Dermatology, University of Rochester Medical Center , Rochester, New York, USA.ORCID 0000-0002-8452-667X
University of Rochester Medical Center · USUniversity of Iowa · US

Funding

Experimental and Computational Analysis of the Human Epidemiology and Response to SARS-CoV-2 (HEROS) CohortUM1AI151958 · NIAID · NATIONAL JEWISH HEALTH · PI Donald YM Leung · 2020 to 2026
$38.3M
Targeted Microbiome Transplant in Atopic DermatitisU19AI117673 · NIAID · NATIONAL JEWISH HEALTH · PI GEHA, RAIF SALIM · 2015 to 2019
$30.6M
The T32 Predoctoral Training Program in Immunology (PTPI)T32AI007285 · NIAID · UNIVERSITY OF ROCHESTER · PI Scott Andrew Gerber, JACQUES Robert · 1986 to 2026
$7.6M
Biomarker Identification, Viral Susceptibility and Management in S. aureus Colonized AD PatientsU01AI152011 · NIAID · UNIVERSITY OF ROCHESTER · PI Lisa Ann Beck · 2020 to 2026
$3.2M
Infection and Immunity: The Pathogenesis of Host-Microbe InteractionsT32AI118689 · NIAID · UNIVERSITY OF ROCHESTER · PI Paul M. Dunman, BRIAN M WARD · 2015 to 2026
$2.5M
HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI007285HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) T32AI118689HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U01AI152011HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) U19AI117673NIAID NIH HHS T32 AI007285NIAID NIH HHS T32 AI118689NIAID NIH HHS U01 AI152011NIAID NIH HHS U19 AI117673NIAID NIH HHS UM1 AI151958
6 · The paper itself

Abstract

importance

Indexed as

atopic dermatitisbarrier functionCD40keratinocytesSElQStaphylococcus aureussuperantigensUSA300vaccinia virusviral infection

Identifiers

PMID37737609
PMCPMC10581065
OpenAlexW4386944719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.